_________ false

אנלייבקס תרפיוטיקס בע"מ	2 359
ENLIVEX THERAPEUTICS LTD
Corporation no: 514716489	12568

	Israel Securities Authority			Tel Aviv Stock Exchange		C304 ( Public )		Reported via MAGNA:	17/07/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-073429	Time of broadcast: 12:51 12:51:00

Initial Details relating to Directors and Senior Management

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto are the details of the directors and senior management as of the 30/06/2019 C304_isa.pdf

Explanation: the details should be as stated in the last 20-F or if the corporation has published updated information since, then those details should be given.

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market: -1	Date of revision of form structure: 25/06/2019
Address: Einstein 14 , NES-ZIONA 7403618   , ISRAEL Tel: 02-6708072 , Fax: 02-6708070
E-mail address: shachar@enlivexpharm.com   Company site: www.enlivex.com
Previous names of reporting entity:
Name of the Signatory: SHLOSBERGER SHACHAR Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company: Enlivex thetraputics R&D
Address: Nachal Dan 19 , Qiryat Uno 61580 Telephone: 054-4617610 Facsimile: - E-mail: shachar@ramdor.co.il 2
ISRAEL